These three cancer stocks have tremendous upside potential.
News & Analysis: AbbVie
Some are really big, while others are relatively small. But all these pharmaceutical stocks look like promising picks for 2019.
Looking for potential winning biotech stocks? These five check off all the boxes for investors.
There's nothing complicated at all about this approach to making a solid profit with one of the top big pharma stocks on the market.
Which of these healthcare titans is the better investment today? The answer might surprise you.
Which stock wins in a matchup between these two healthcare giants?
Looking for big dividend payers? Here is a diversified trio of stocks that you need to take a look at today -- before their high yields are a thing of the past.
These stocks are dirt cheap. But perhaps not for too much longer.
Hint: In pretty good shape.
AbbVie and Eli Lilly are two rock-solid dividend plays, but only one is a buy right now.